SAR: Side Effects and Drug Design
Sep 2020 · CRC Press
e-Buku
384
Halaman
family_home
Layak
info
reportRating dan ulasan tidak disahkan Ketahui Lebih Lanjut
Perihal e-buku ini
This book focuses on the quantitative structure-activity relationship of the disposition and activities of various pharmacological groups. It presents a systematic approach for linking different side effect of drugs to their molecular structure and physiochemical properties.
Perihal pengarang
Eric J. Lien is Professor of Pharmacy and Biomedical Chemistry at the University of Southern California School of Pharmacy, Los Angeles. Dr. Lien is the author of SAR Analysis and Anticancer Chinese Drugs and Related Plants and U.S. New Drug Digest, 1980-86, as well as over 160 scientific papers and chapters in pharmaceutical textbooks. He is on the editorial boards of Journal of Clinical and Hospital Pharmacy and Oriental Healing Arts International Bulletin. A member of many scientific and professional societies, Dr. Lien also serves as a consultant to the National Institutes of Health. He received the B.S. (1960) degree in pharmacy from the School of Pharmacy, College of Medicine, National Taiwan University, Ph.D. (1966) degree in pharmaceutical chemistry from the University of California, San Francisco Medical Center, and did postdoctoral work (1968) at Pomona College, Claremont, California.
Berikan rating untuk e-Buku ini
Beritahu kami pendapat anda.
Maklumat pembacaan
Telefon pintar dan tablet
Pasang apl Google Play Books untuk Android dan iPad/iPhone. Apl ini menyegerak secara automatik dengan akaun anda dan membenarkan anda membaca di dalam atau luar talian, walau di mana jua anda berada.
Komputer riba dan komputer
Anda boleh mendengar buku audio yang dibeli di Google Play menggunakan penyemak imbas web komputer anda.
eReader dan peranti lain
Untuk membaca pada peranti e-dakwat seperti Kobo eReaders, anda perlu memuat turun fail dan memindahkan fail itu ke peranti anda. Sila ikut arahan Pusat Bantuan yang terperinci untuk memindahkan fail ke e-Pembaca yang disokong.
